8-K: Akoustis Technologies Faces Nasdaq Delisting Threat Due to Stockholders' Equity Deficit

Sentiment:

Delisting Notice


Akoustis Technologies has received a notice from Nasdaq for failing to meet the minimum stockholders' equity requirement, adding to existing delisting concerns due to low share price.

Worse than expectedThe company has a significant stockholders' deficit of approximately $57.1 million, which is well below the required $2.5 million minimum.The company is also facing delisting due to a failure to maintain a minimum bid price of $1.00 per share.

Summary

  • Akoustis Technologies received a notice from Nasdaq on October 10, 2024, stating they do not meet the minimum stockholders' equity requirement of $2.5 million for continued listing.
  • The company reported a stockholders' deficit of approximately $57.1 million in its annual report for the fiscal year ended June 30, 2024.
  • This notice is in addition to a previous notice regarding the company's failure to maintain a minimum bid price of $1.00 per share.
  • The company appealed the delisting determination related to the bid price and presented a compliance plan for the stockholders' equity requirement at a hearing on October 8, 2024.
  • The Nasdaq Hearings Panel's decision is pending, and the company's stock will continue to trade on the Nasdaq Capital Market while the decision is pending.
  • There is no guarantee that the Panel will grant a compliance period or that the company will regain compliance with all listing requirements.

Sentiment

Score: 2

Explanation: The document indicates significant financial distress and a high risk of delisting, which is a very negative signal for investors.

Positives

  • The suspension of trading of the company's common stock has been stayed while the Panel's decision is pending.
  • The company has presented a compliance plan to the Panel in respect of the Stockholders Equity Requirement.

Negatives

  • The company has a significant stockholders' deficit of approximately $57.1 million.
  • The company is facing potential delisting from the Nasdaq Capital Market due to both low stock price and insufficient stockholders' equity.
  • There is no assurance that the company will be granted a compliance period or regain compliance with listing requirements.

Risks

  • The Nasdaq Hearings Panel may not grant the company a compliance period.
  • The company may not be able to regain compliance with the minimum bid price and stockholders' equity requirements.
  • Delisting from Nasdaq would negatively impact the company's ability to raise capital and its overall financial condition.
  • The company faces substantial costs and diversion of personnel's attention and resources due to these matters.

Future Outlook

The company's future on the Nasdaq Capital Market is uncertain, pending the Nasdaq Hearings Panel's decision on compliance with both the minimum bid price and stockholders' equity requirements. There is no guarantee of a compliance period or that the company will regain compliance.

Management Comments

  • The company expects that the Panel's decision following the Hearing will address the company's compliance with both the Bid Price Requirement and the Stockholders Equity Requirement.
  • The company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Industry Context

This announcement highlights the challenges faced by companies in maintaining listing requirements, particularly in volatile market conditions. It is not uncommon for companies to face delisting threats due to low stock prices or financial difficulties, which can impact investor confidence and access to capital.

Comparison to Industry Standards

  • Many companies on the Nasdaq Capital Market struggle to maintain the minimum $2.5 million stockholders' equity requirement, especially during periods of financial difficulty or market downturns.
  • Companies like Akoustis, which are in the technology sector, often face challenges in maintaining profitability and positive equity, particularly during early stages of development or when facing significant competition.
  • Other companies that have faced similar delisting issues include those in the biotech and resource sectors, where high research and development costs or volatile commodity prices can impact financial performance.
  • The situation is similar to other companies that have received delisting notices for failing to maintain minimum bid prices, such as those in the small-cap and micro-cap segments.

Stakeholder Impact

  • Shareholders face the risk of significant losses if the company is delisted.
  • Employees may experience uncertainty about the company's future.
  • The company's ability to raise capital and conduct business may be severely impacted.

Next Steps

  • The company is awaiting the Nasdaq Hearings Panel's decision regarding its compliance plan.
  • The company may need to take further actions to regain compliance with listing requirements if granted a compliance period.

Key Dates

DateDescription
2024-06-30End of the fiscal year for which the company reported a stockholders' deficit.
2024-08-16End of the 10-consecutive trading day period where the bid price closed at $0.10 or less per share.
2024-08-19Date the company received notice from Nasdaq indicating the bid price was below $0.10.
2024-10-08Date the company filed its Annual Report on Form 10-K and the date of the hearing before the Nasdaq Hearings Panel.
2024-10-10Date the company received the notice from Nasdaq regarding the stockholders' equity requirement.
2024-10-11Date of the 8-K filing.

Keywords

delisting, Nasdaq, stockholders' equity, minimum bid price, compliance, AKTS, hearing, deficit

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.